Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Sachin Wani to Adenocarcinoma

This is a "connection" page, showing publications Sachin Wani has written about Adenocarcinoma.

 
Connection Strength
  
 
 
11.271
  
  1. Smith ZL, Thorgerson AM, Dawson AZ, Wani S. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy. Dig Dis Sci. 2023 12; 68(12):4439-4448.
    View in: PubMed
    Score: 0.564
  2. Wani S, Holmberg D, Santoni G, Kauppila JH, Farkkila M, von Euler-Chelpin M, Shaheen NJ, Lagergren J. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study. Gastroenterology. 2023 10; 165(4):909-919.e13.
    View in: PubMed
    Score: 0.550
  3. Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 04 01; 117(4):559-587.
    View in: PubMed
    Score: 0.507
  4. Wani S, Yadlapati R, Singh S, Sawas T, Katzka DA. Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel. Gastroenterology. 2022 02; 162(2):366-372.
    View in: PubMed
    Score: 0.491
  5. Han S, Kolb JM, Hosokawa P, Friedman C, Fox C, Scott FI, Lieu CH, Vajravelu RK, McCarter M, Murphy CC, Cook MB, Gleisner A, Falk GW, Katzka DA, Wani S. The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry. Am J Gastroenterol. 2021 04; 116(4):811-815.
    View in: PubMed
    Score: 0.473
  6. Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep. 2020 Dec 04; 22(12):61.
    View in: PubMed
    Score: 0.462
  7. Wani S, Williams JL, Falk GW, Komanduri S, Muthusamy VR, Shaheen NJ. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines. Am J Gastroenterol. 2020 11; 115(11):1869-1878.
    View in: PubMed
    Score: 0.460
  8. Wani S. Advances and Opportunities in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2021 Jan; 31(1):xv-xvi.
    View in: PubMed
    Score: 0.459
  9. Wani S, Gyawali CP, Katzka DA. AGA Clinical Practice Update on Reducing Rates of Post-Endoscopy Esophageal Adenocarcinoma: Commentary. Gastroenterology. 2020 10; 159(4):1533-1537.
    View in: PubMed
    Score: 0.450
  10. Kolb JM, Wani S. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Curr Opin Gastroenterol. 2020 07; 36(4):351-358.
    View in: PubMed
    Score: 0.449
  11. Machicado JD, Obuch JC, Goodman KA, Schefter TE, Frakes J, Hoffe S, Latifi K, Simon VC, Santangelo T, Ezekwe E, Edmundowicz SA, Brauer BC, Shah RJ, Hammad HT, Wagh MS, Attwell A, Han S, Klapman J, Wani S. Endoscopic Ultrasound Placement of Preloaded Fiducial Markers Shortens Procedure Time Compared to Back-Loaded Markers. Clin Gastroenterol Hepatol. 2019 12; 17(13):2749-2758.e2.
    View in: PubMed
    Score: 0.414
  12. Rubenstein JH, Waljee AK, Dwamena B, Bergman J, Vieth M, Wani S. Yield of Higher-Grade Neoplasia in Barrett's Esophagus With?Low-Grade Dysplasia Is Double in the First Year Following?Diagnosis. Clin Gastroenterol Hepatol. 2018 09; 16(9):1529-1530.
    View in: PubMed
    Score: 0.378
  13. Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1056-1060.
    View in: PubMed
    Score: 0.365
  14. Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. J Clin Gastroenterol. 2017 01; 51(1):2-11.
    View in: PubMed
    Score: 0.352
  15. Mounzer R, Das A, Yen RD, Rastogi A, Bansal A, Hosford L, Wani S. Endoscopic and surgical treatment of malignant colorectal polyps: a population-based comparative study. Gastrointest Endosc. 2015 Mar; 81(3):733-740.e2.
    View in: PubMed
    Score: 0.310
  16. Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci. 2013 Jun; 58(6):1703-9.
    View in: PubMed
    Score: 0.273
  17. Wani S, Early D, Edmundowicz S, Sharma P. Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):704-11.
    View in: PubMed
    Score: 0.254
  18. Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, Gupta N, Gaddam S, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Goldblum J, Lieberman DA, Sampliner RE, Sharma P. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology. 2011 Oct; 141(4):1179-86, 1186.e1.
    View in: PubMed
    Score: 0.240
  19. Wani S. Population-based estimates of cancer and mortality in Barrett's esophagus: implications for the future. Clin Gastroenterol Hepatol. 2011 Sep; 9(9):723-4.
    View in: PubMed
    Score: 0.239
  20. Wani S, Falk G, Hall M, Gaddam S, Wang A, Gupta N, Singh M, Singh V, Chuang KY, Boolchand V, Gavini H, Kuczynski J, Sud P, Reddymasu S, Bansal A, Rastogi A, Mathur SC, Young P, Cash B, Lieberman DA, Sampliner RE, Sharma P. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011 Mar; 9(3):220-7; quiz e26.
    View in: PubMed
    Score: 0.231
  21. Wani S, Sayana H, Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc. 2010 Jan; 71(1):147-66.
    View in: PubMed
    Score: 0.214
  22. Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A, Rastogi A, Sayana H, Sharma P. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol. 2009 Feb; 104(2):502-13.
    View in: PubMed
    Score: 0.203
  23. Wani S, Sharma P. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):128-9.
    View in: PubMed
    Score: 0.190
  24. Peabody JW, Cruz JDC, Ganesan D, Paculdo D, Critchley-Thorne RJ, Wani S, Shaheen NJ. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB. Clin Transl Gastroenterol. 2024 01 01; 15(1):e00644.
    View in: PubMed
    Score: 0.143
  25. Han S, Turkeltaub JA, Jonas D, Attwell AR, Duloy AM, Edmundowicz SA, Hammad HT, Wagh MS, Wani S, Shah RJ. The timing of recurrence after endoscopic papillectomy. Surg Endosc. 2024 Feb; 38(2):688-696.
    View in: PubMed
    Score: 0.142
  26. Sijben J, Rainey L, Peters Y, Fitzgerald RC, Wani S, Kolb JM, Broeders MJM, Siersema PD. Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study. BMC Cancer. 2023 Nov 14; 23(1):1111.
    View in: PubMed
    Score: 0.142
  27. Pratap A, Qualman A, Garrett H, The E, Chauhan A, Idrovo JP, Cheng L, Wani S, Meguid RA, Meng X. Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells. Anticancer Res. 2023 Aug; 43(8):3411-3418.
    View in: PubMed
    Score: 0.139
  28. Muthusamy VR, Wani S, Gyawali CP, Komanduri S. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review. Clin Gastroenterol Hepatol. 2022 12; 20(12):2696-2706.e1.
    View in: PubMed
    Score: 0.129
  29. Sawas T, Majzoub AM, Haddad J, Tielleman T, Nayfeh T, Yadlapati R, Singh S, Kolb J, Vajravelu RK, Katzka DA, Wani S. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 02; 20(2):e31-e50.
    View in: PubMed
    Score: 0.119
  30. Ho F, Torphy RJ, Friedman C, Leong S, Kim S, Wani S, Schefter T, Scott CD, Mitchell JD, Weyant MJ, Meguid RA, Gleisner AL, Goodman KA, McCarter MD. Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2021 Nov; 28(12):7208-7218.
    View in: PubMed
    Score: 0.119
  31. Kolb JM, Han S, Scott FI, Murphy CC, Hosokawa P, Wani S. Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals. Gastroenterology. 2020 12; 159(6):2238-2240.e4.
    View in: PubMed
    Score: 0.113
  32. Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019 09; 90(3):335-359.e2.
    View in: PubMed
    Score: 0.106
  33. Omar M, Thaker AM, Wani S, Simon V, Ezekwe E, Boniface M, Edmundowicz S, Obuch J, Cinnor B, Brauer BC, Wood M, Early DS, Lang GD, Mullady D, Hollander T, Kushnir V, Komanduri S, Muthusamy VR. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy. Gastrointest Endosc. 2019 09; 90(3):395-403.
    View in: PubMed
    Score: 0.103
  34. Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fern?ndez-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ. Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia. Gastrointest Endosc. 2019 02; 89(2):247-256.e4.
    View in: PubMed
    Score: 0.099
  35. Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology. 2018 06; 154(8):2068-2086.e5.
    View in: PubMed
    Score: 0.095
  36. Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017 Jun; 112(6):849-865.
    View in: PubMed
    Score: 0.090
  37. Mallick R, Patnaik SK, Wani S, Bansal A. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus. Dig Dis Sci. 2016 Apr; 61(4):1039-50.
    View in: PubMed
    Score: 0.081
  38. Ge PS, Hamerski CM, Watson RR, Komanduri S, Cinnor BB, Bidari K, Klapman JB, Lin CL, Shah JN, Wani S, Donahue TR, Muthusamy VR. Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy. Gastrointest Endosc. 2015 Feb; 81(2):360-6.
    View in: PubMed
    Score: 0.076
  39. Wani S, Das A, Rastogi A, Drahos J, Ricker W, Parsons R, Bansal A, Yen R, Hosford L, Jankowski M, Sharma P, Cook MB. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study. Cancer. 2015 Jan 15; 121(2):194-201.
    View in: PubMed
    Score: 0.075
  40. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):84-90.
    View in: PubMed
    Score: 0.073
  41. Tofteland N, Singh M, Gaddam S, Wani SB, Gupta N, Rastogi A, Bansal A, Kanakadandi V, McGregor DH, Ulusarac O, Cherian R, Mathur SC, Sharma P. Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists. Dis Esophagus. 2014 Sep-Oct; 27(7):623-9.
    View in: PubMed
    Score: 0.070
  42. Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. Gastroenterology. 2013 Sep; 145(3):548-53.e1.
    View in: PubMed
    Score: 0.069
  43. Anaparthy R, Gaddam S, Kanakadandi V, Alsop BR, Gupta N, Higbee AD, Wani SB, Singh M, Rastogi A, Bansal A, Cash BD, Young PE, Lieberman DA, Falk GW, Vargo JJ, Thota P, Sampliner RE, Sharma P. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1430-6.
    View in: PubMed
    Score: 0.069
  44. Giacchino M, Bansal A, Kim RE, Singh V, Hall SB, Singh M, Rastogi A, Moloney B, Wani SB, Gaddam S, Mathur SC, Wallace MB, Kanakadandi V, Balasubramanian G, Gupta N, Sharma P. Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett's esophagus: a prospective tandem study. Gastrointest Endosc. 2013 May; 77(5):711-8.
    View in: PubMed
    Score: 0.067
  45. Wani S. Management of low-grade dysplasia in Barrett's esophagus. Curr Opin Gastroenterol. 2012 Jul; 28(4):370-6.
    View in: PubMed
    Score: 0.064
  46. Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Sharma P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc. 2012 Sep; 76(3):531-8.
    View in: PubMed
    Score: 0.064
  47. Gaddam S, Mathur SC, Singh M, Arora J, Wani SB, Gupta N, Overhiser A, Rastogi A, Singh V, Desai N, Hall SB, Bansal A, Sharma P. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2011 Nov; 106(11):1961-9.
    View in: PubMed
    Score: 0.061
  48. Singh M, Bansal A, Curvers WL, Kara MA, Wani SB, Alvarez Herrero L, Lynch CR, van Kouwen MC, Peters FT, Keighley JD, Rastogi A, Pondugula K, Kim R, Singh V, Gaddam S, Bergman JJ, Sharma P. Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study. Endoscopy. 2011 Sep; 43(9):745-51.
    View in: PubMed
    Score: 0.061
  49. Gupta N, Bansal A, Wani SB, Gaddam S, Rastogi A, Sharma P. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointest Endosc. 2011 Sep; 74(3):610-624.e2.
    View in: PubMed
    Score: 0.060
  50. Pondugula K, Wani S, Sharma P. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else? Curr Gastroenterol Rep. 2007 Dec; 9(6):468-74.
    View in: PubMed
    Score: 0.047
  51. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008 Mar; 67(3):394-8.
    View in: PubMed
    Score: 0.047
  52. Sharma P, Wani S, Rastogi A. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: ablate, resect, or both? Gastrointest Endosc. 2007 Sep; 66(3):469-74.
    View in: PubMed
    Score: 0.046
  53. Sharma P, Wani S. Advances in esophageal imaging: practical applications for clinicians. Rev Gastroenterol Disord. 2006; 6 Suppl 1:S12-8.
    View in: PubMed
    Score: 0.041
  54. Wani S, Sharma P. The rationale for screening and surveillance of Barrett's metaplasia. Best Pract Res Clin Gastroenterol. 2006; 20(5):829-42.
    View in: PubMed
    Score: 0.041
  55. Han S, Tatman P, Mehrotra S, Wani S, Attwell AR, Edmundowicz SA, Brauer BC, Wagh MS, Hammad HT, Shah RJ. Combination of ERCP-Based Modalities Increases Diagnostic Yield for Biliary Strictures. Dig Dis Sci. 2021 04; 66(4):1276-1284.
    View in: PubMed
    Score: 0.028
  56. El Hajj II, Brauer BC, Wani S, Fukami N, Attwell AR, Shah RJ. Role of per-oral pancreatoscopy in the evaluation of suspected?pancreatic duct neoplasia: a 13-year U.S. single-center experience. Gastrointest Endosc. 2017 Apr; 85(4):737-745.
    View in: PubMed
    Score: 0.021
  57. Bansal A, McGregor DH, Anand O, Singh M, Rao D, Cherian R, Wani SB, Rastogi A, Singh V, House J, Jones PG, Sharma P. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus. Dis Esophagus. 2014 Nov-Dec; 27(8):751-6.
    View in: PubMed
    Score: 0.018
  58. Bansal A, Lee IH, Hong X, Anand V, Mathur SC, Gaddam S, Rastogi A, Wani SB, Gupta N, Visvanathan M, Sharma P, Christenson LK. Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol. 2011 Jun; 106(6):1055-63.
    View in: PubMed
    Score: 0.015
  59. Sharma P, Wani S, Bansal A. The quest for intestinal metaplasia--is it worth the effort? Am J Gastroenterol. 2007 Jun; 102(6):1162-5.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)